With the rapid development and complex challenges of chemical substances, new drug synthesis pathways are usually the most effective.829-85-6,Diphenylphosphine,as a common compound, the synthetic route is as follows.
829-85-6, General procedure: MCM-41-3N-Pd(0) (21mg, 0.01mmol), KOAc (1.5mmol) and aryl iodide 1 (1.0mmol) (if solid) were placed in an oven-dried 20mL Schlenk tube, the reaction vessel was evacuated and filled with argon for three times. Then aryl iodide 1 (1.0mmol) (if liquid), diphenylphosphine (1.2mmol) and DMAc (1mL) were added with a syringe under a counter flow of argon. The reaction mixture was stirred at 130C for 3h. After completion of the reaction, the mixture was cooled to room temperature and diluted with CH2Cl2 (20mL) and filtered. The MCM-41-3N-Pd(0) catalyst was washed with distilled water (2¡Á5mL) and ethanol (2¡Á5mL), and reused in the next run. The filtrate was concentrated in vacuo and the residue was purified by flash column chromatography on silica gel to provide the product 2.
As the paragraph descriping shows that 829-85-6 is playing an increasingly important role.
Reference£º
Short Survey; Xu, Zhaotao; Wang, Pingping; Chen, Qiurong; Cai, Mingzhong; Journal of Organometallic Chemistry; vol. 866; (2018); p. 50 – 58;,
Phosphine ligand
Chiral phosphine ligands in asymmetric synthesis. Molecular structure and absolute configuration of (1,5-cyclooctadiene)-(2S,3S)-2,3-bis(diphenylphosphino)butanerhodium(I) perchlorate tetrahydrofuran solvate